Rabu, 10 Juni 2026 - 08:00 WIB

Find and Follow Us

Global Markets

IHSG 5,746.65 +7.57%

S&P 500 7,386.65 -0.26%

NASDAQ 25,678.82 -0.97%

Dow Jones 50,872.11 +0.17%

FTSE 100 10,227.33 -1.41%

CAC 40 8,203.43 +0.05%

Nikkei 225 64,532.73 +0.00%

Hang Seng 24,565.90 -0.37%

Shanghai 4,010.03 +1.28%

KOSPI 7,883.61 +0.00%

STI 5,023.25 +0.00%

ASX 200 8,627.50 +0.00%

Sensex 73,918.76 +0.54%

Gold 4,228.20 -2.48%

Silver 64.65 -5.52%

Oil (WTI) 89.57 -1.89%

Brent 92.90 -1.43%

Copper 6.33 -0.04%

Gas Alam 3.14 -0.38%

Bitcoin 61,865.77 +0.00%

Ethereum 1,644.65 +0.00%

USD/IDR 18,136.00 -0.30%

EUR/USD 1.15 +0.14%

Advertisement

Ilustrasi Ahli Kesehatan Peneliti Obat Covid-19 (ist)

Alhamdulilah, Kabar Baik! Obat Covid-19 Unggulan Molnupiravir Bakal Hadir di Indonesia

Redaksi • 07 Oktober 2021

Latest Updates

- Advertisement -

Ilustrasi Ahli Kesehatan Peneliti Obat Covid-19 (ist)

07:40 WIB • 07 Oktober 2021

Alhamdulilah, Kabar Baik! Obat Covid-19 Unggulan Molnupiravir Bakal Hadir di Indonesia

Jakarta– Obat Covid-19, Molnupiravir buatan perusahaan farmasi Merck & Co digadang-gadang menjadi obat unggulan setelah…